dosage adjustment of tirzepatide is suggested for patients with hepatic impairment. However, tirzepatide is associated with gastrointestinal

place of medical care and advice from your healthcare provider. What is tirzepatide? Tirzepatide is a

GLP-1 backbone: Dulaglutide Albiglutide - discontinued Liraglutide Semaglutide Exendin-4 backbone: Exenatide (2 formulations) Lixisenatide - discontinued Tirzepatide is a GIP

and body weight loss when switching from semaglutide or dulaglutide to once weekly tirzepatide. [Curr Med Res Opin

Linagliptin , Saxagliptin , Sitagliptin Glucagon-Like Peptide-1 (GLP-1) Analogues Albiglutide , Dulaglutide , Exenatide , Liraglutide , Lixisenatide , Semaglutide , Tirzepatide Insulin Metformin Metiglinide Analogues

Linagliptin Saxagliptin Sitagliptin Glucagon-Like Peptide-1 (GLP-1) Analogues Albiglutide Dulaglutide Exenatide Liraglutide Lixisenatide Semaglutide Tirzepatide Insulin Metformin Metiglinide Analogues

subcutaneous Exenatide injectable suspension SC Liraglutide SC Liraglutide/insulin degludec  Lixisenatide/insulin glargine Semaglutide (oral, SC) Tirzepatide (dual GIP/GLP-1

GLP-1 backbone: Dulaglutide Albiglutide - discontinued Liraglutide Semaglutide Exendin-4 backbone: Exenatide (2 formulations) Lixisenatide - discontinued Tirzepatide is a GIP

Subclass, Incretin-Based Drugs , Glucagon-Like Peptide-1 (GLP-1) Analogues : Albiglutide , Dulaglutide , Exenatide , Liraglutide , Lixisenatide , Tirzepatide CASE REPORT Case 1